The Nordic pharmaceutical market grew slightly during February–October 2009. The growth in Denmark (4.9%) resulted from hospital sales, while the size of the pharmacy sector stayed at the previous level. The growth in Norway (4.2%) resulted mainly from lower price decreases in pharmaceutical products than last year.
In Latvia and Lithuania, the economic slowdown strongly impacted consumer demand, leading also to a decline in pharmaceutical sales. The Estonian pharmaceutical market has not been impacted as strongly and the market grew slightly.
In Poland, the stable pharmaceutical growth continued during the third quarter.
